Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ELI LILLY & CoLLY · Entity 2794 | Director | November 20, 2017 | November 22, 2017 |
| Elanco Animal Health IncELAN · Entity 3457 | Director | May 21, 2026 | May 26, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ELI LILLY & Co
Report date November 20, 2017 · Filed November 22, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 36,284 |
Reported balance
After 2017-11-20 transaction · row 1
1 source rowRow 1 · 2017-11-20 · Grant · Acquired 1,924 · Balance 36,284 |
| Common StockSEC Table I · non-derivative | IndirectSuzanne A. Hoover Revocable Trust | 1,500 |
Reported balance
Holding disclosure · report date 2017-11-20 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 1,500 F1: Revocable Trust of which reporting person's spouse is the trustee. |
Filing footnotes · ownership attribution and instrument terms
F1: Revocable Trust of which reporting person's spouse is the trustee.
Elanco Animal Health Inc
Report date May 21, 2026 · Filed May 26, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 111,451 |
Reported balance
After 2026-05-21 transaction · row 1
1 source rowRow 1 · 2026-05-21 · Grant · Acquired 4,678 · Balance 111,451 F1: Grant of deferred stock units as a pro-rated annual equity award to each of the non-employee members of the Issuer's Board of Directors. |
| Common StockSEC Table I · non-derivative | IndirectRevocable Trust | 150,000 |
Reported balance
Holding disclosure · report date 2026-05-21 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 150,000 |
| Common StockSEC Table I · non-derivative | IndirectSuzanne A. Hoover Revocable Trust | 15,920 |
Reported balance
Holding disclosure · report date 2026-05-21 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 15,920 |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of deferred stock units as a pro-rated annual equity award to each of the non-employee members of the Issuer's Board of Directors.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
BALL Corp
Report date April 25, 2018 · Filed April 25, 2018
Section 16 reporting ended · disclosed 2018-04-25. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 192,811.0889 |
Reported balance
Holding disclosure · report date 2018-04-25 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 192,811.0889 |
| Common StockSEC Table I · non-derivative | IndirectRDH Trust | 971,090 |
Reported balance
Holding disclosure · report date 2018-04-25 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 971,090 |
| Deferred Compensation Company Stock PlanSEC Table II · derivative / convertible security | Direct | 11,152.1288 |
Reported balance
Holding disclosure · report date 2018-04-25 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 11,152.1288 F1: Each unit may be settled for a single share of stock or the equivalent amount of cash pursuant to the Ball Corporation Deferred Compensation Company Stock Plan. F2: Stock units in Ball Corporation's Deferred Compensation Company Stock Plan are distributed upon the separation of service in accordance with the Plan. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 38,542 |
Reported balance
Holding disclosure · report date 2018-04-25 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 38,542 F3: Each restricted stock unit represents a contingent right to receive one share of Ball Corporation Common Stock. |
| Stock Appreciation Rights (sars)SEC Table II · derivative / convertible security · Conversion / exercise price $10.02 · Expires 2019-01-28 | Direct | 800,000 |
Reported balance
Holding disclosure · report date 2018-04-25 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 800,000 |
| Stock Appreciation Rights (sars)SEC Table II · derivative / convertible security · Conversion / exercise price $12.61 · Expires 2020-01-27 | Direct | 516,400 |
Reported balance
Holding disclosure · report date 2018-04-25 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 516,400 |
| Stock Option (iso) (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $12.61 · Expires 2020-01-27 | Direct | 13,600 |
Reported balance
Holding disclosure · report date 2018-04-25 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 13,600 |
Filing footnotes · ownership attribution and instrument terms
F1: Each unit may be settled for a single share of stock or the equivalent amount of cash pursuant to the Ball Corporation Deferred Compensation Company Stock Plan.
F2: Stock units in Ball Corporation's Deferred Compensation Company Stock Plan are distributed upon the separation of service in accordance with the Plan.
F3: Each restricted stock unit represents a contingent right to receive one share of Ball Corporation Common Stock.
EDGEWELL PERSONAL CARE Co
Report date February 03, 2021 · Filed February 05, 2021
Section 16 reporting ended · disclosed 2021-02-05. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 46,724 |
Reported balance
After 2021-02-03 transaction · row 1
1 source rowRow 1 · 2021-02-03 · Exercise / conversion · Acquired 20,839 · Balance 46,724 F1: Total of the previously deferred Restricted Stock Equivalents as reported here in Table II converted into shares of Edgewell common stock due to Mr. Hoover's retirement from the Board of Directors on February 3, 2021. |
| Restricted Stock EquivalentsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2021-02-03 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2021-02-03 · Other · Disposed 10,000 · Balance 0 F2: Previously deferred Restricted Stock Equivalents converted into shares of Edgewell common stock due to Mr. Hoover's retirement from the Board of Directors on February 3, 2021. |
| Restricted Stock Equivalents 1-3-2017SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2021-02-03 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2021-02-03 · Other · Disposed 1,667 · Balance 0 F2: Previously deferred Restricted Stock Equivalents converted into shares of Edgewell common stock due to Mr. Hoover's retirement from the Board of Directors on February 3, 2021. |
| Restricted Stock Equivalents 1-2-2018SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2021-02-03 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2021-02-03 · Other · Disposed 2,072 · Balance 0 F2: Previously deferred Restricted Stock Equivalents converted into shares of Edgewell common stock due to Mr. Hoover's retirement from the Board of Directors on February 3, 2021. |
| Restricted Stock Equivalents 2-1-2019SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2021-02-03 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2021-02-03 · Other · Disposed 3,156 · Balance 0 F2: Previously deferred Restricted Stock Equivalents converted into shares of Edgewell common stock due to Mr. Hoover's retirement from the Board of Directors on February 3, 2021. |
| Restricted Stock Equivalents 2-6-2020SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2021-02-03 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2021-02-03 · Other · Disposed 3,944 · Balance 0 F2: Previously deferred Restricted Stock Equivalents converted into shares of Edgewell common stock due to Mr. Hoover's retirement from the Board of Directors on February 3, 2021. |
| Common StockSEC Table I · non-derivative | IndirectSuzanne A. Hoover Revocable Trust | 10,000 |
Reported balance
Holding disclosure · report date 2021-02-03 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 10,000 |
Filing footnotes · ownership attribution and instrument terms
F1: Total of the previously deferred Restricted Stock Equivalents as reported here in Table II converted into shares of Edgewell common stock due to Mr. Hoover's retirement from the Board of Directors on February 3, 2021.
F2: Previously deferred Restricted Stock Equivalents converted into shares of Edgewell common stock due to Mr. Hoover's retirement from the Board of Directors on February 3, 2021.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 03, 2021 Filed Feb 5, 2021 13:37 UTC | EDGEWELL PERSONAL CARE Co EPC · Entity 4787 | OtherRestricted Stock Equivalents 1-2-2018 · Derivative | 2,072 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-007992 · doc4.xml · derivative · entry 5 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,072 shares Expires not disclosed F2 · derivative.exercise_date: Previously deferred Restricted Stock Equivalents converted into shares of Edgewell common stock due to Mr. Hoover's retirement from the Board of Directors on February 3, 2021. F2 · derivative.expiration_date: Previously deferred Restricted Stock Equivalents converted into shares of Edgewell common stock due to Mr. Hoover's retirement from the Board of Directors on February 3, 2021. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 13:37 UTC | EDGEWELL PERSONAL CARE Co EPC · Entity 4787 | OtherRestricted Stock Equivalents 1-3-2017 · Derivative | 1,667 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-007992 · doc4.xml · derivative · entry 4 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,667 shares Expires not disclosed F2 · derivative.exercise_date: Previously deferred Restricted Stock Equivalents converted into shares of Edgewell common stock due to Mr. Hoover's retirement from the Board of Directors on February 3, 2021. F2 · derivative.expiration_date: Previously deferred Restricted Stock Equivalents converted into shares of Edgewell common stock due to Mr. Hoover's retirement from the Board of Directors on February 3, 2021. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 13:37 UTC | EDGEWELL PERSONAL CARE Co EPC · Entity 4787 | OtherRestricted Stock Equivalents · Derivative | 10,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-007992 · doc4.xml · derivative · entry 3 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires not disclosed F2 · derivative.exercise_date: Previously deferred Restricted Stock Equivalents converted into shares of Edgewell common stock due to Mr. Hoover's retirement from the Board of Directors on February 3, 2021. F2 · derivative.expiration_date: Previously deferred Restricted Stock Equivalents converted into shares of Edgewell common stock due to Mr. Hoover's retirement from the Board of Directors on February 3, 2021. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 13:37 UTC | EDGEWELL PERSONAL CARE Co EPC · Entity 4787 | Exercise / conversionCommon Stock | 20,839 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-007992 · doc4.xml · nonDerivative · entry 1 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,724 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Total of the previously deferred Restricted Stock Equivalents as reported here in Table II converted into shares of Edgewell common stock due to Mr. Hoover's retirement from the Board of Directors on February 3, 2021. Read SEC document |
| January 29, 2021 Filed Mar 2, 2021 21:56 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 533.9304 | $29.03 | $15,500.00 |
DisclosureSEC source: 0000950138-21-000162 · edgar.xml · derivative · entry 1 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,905.0228 Underlying: Common Stock · 533.9304 shares Expires not disclosed F1 · security: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F2 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $29.03 on January 29, 2021. F2 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $29.03 on January 29, 2021. F1 · derivative.exercise_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F1 · derivative.expiration_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. Read SEC document |
| December 31, 2020 Filed Feb 16, 2021 21:25 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 505.3799 | $30.67 | $15,500.00 |
DisclosureSEC source: 0000950138-21-000123 · edgar.xml · derivative · entry 1 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,371.0924 Underlying: Common Stock · 505.3799 shares Expires not disclosed F1 · security: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F2 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $30.67 on December 31, 2020. F2 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $30.67 on December 31, 2020. F1 · derivative.exercise_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F1 · derivative.expiration_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F4 · balance_after: Represents an aggregate amount of Deferred Stock Units owned by the reporting person as of fiscal year end, which includes Deferred Stock Units which were inadvertently excluded from prior filings, awarded during the years of 2019 and 2020. The number of Deferred Stock Units issued on each such award date is the amount of cash deferred divided by the closing price of a share of Elanco common stock on the award date. Read SEC document |
| November 30, 2020 Filed Dec 2, 2020 23:16 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 5,885 | $0.00 | $0.00 |
DisclosureSEC source: 0000950138-20-000507 · edgar.xml · nonDerivative · entry 1 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,960 F1 · price: Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors. Read SEC document |
| August 28, 2020 Filed Aug 28, 2020 22:28 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | PurchaseCommon Stock | 5,000 | $28.62 | $143,100.00 |
DisclosureSEC source: 0000950138-20-000356 · edgar.xml · nonDerivative · entry 2 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Revocable Trust Disclosed balance after: 45,000 Read SEC document |
| August 27, 2020 Filed Aug 28, 2020 22:28 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | PurchaseCommon Stock | 5,000 | $28.24 | $141,200.00 |
DisclosureSEC source: 0000950138-20-000356 · edgar.xml · nonDerivative · entry 1 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,075 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $28.216 to $28.250, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| August 21, 2020 Filed Aug 24, 2020 22:05 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | PurchaseCommon Stock | 10,000 | $26.94 | $269,400.00 |
DisclosureSEC source: 0000950138-20-000352 · edgar.xml · nonDerivative · entry 1 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,075 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $26.870 to $27.011, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| March 13, 2020 Filed Mar 16, 2020 20:14 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | PurchaseCommon Stock | 12,000 | $21.97 | $263,640.00 |
DisclosureSEC source: 0000950138-20-000170 · edgar.xml · nonDerivative · entry 1 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Revocable Trust Disclosed balance after: 40,000 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $21.325 to $22.323, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| March 02, 2020 Filed Mar 3, 2020 23:01 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | PurchaseCommon Stock | 3,900 | $27.40 | $106,860.00 |
DisclosureSEC source: 0000950138-20-000136 · edgar.xml · nonDerivative · entry 2 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Revocable Trust Disclosed balance after: 28,000 F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $27.475 to $27.334, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 23:01 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | PurchaseCommon Stock | 4,100 | $26.99 | $110,659.00 |
DisclosureSEC source: 0000950138-20-000136 · edgar.xml · nonDerivative · entry 1 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Revocable Trust Disclosed balance after: 24,100 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $26.95 to $27.045, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| February 06, 2020 Filed Feb 10, 2020 14:41 UTC | EDGEWELL PERSONAL CARE Co EPC · Entity 4787 | GrantRestricted Stock Equivalent 02/06/2020 · Derivative | 3,944 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-007776 · doc4.xml · derivative · entry 1 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,944 Underlying: Common Stock · 3,944 shares Expires not disclosed F1 · derivative.exercise_date: Restricted stock equivalents convert into shares of Edgewell Common Stock on the day preceding the next annual meeting of shareholders unless Reporting Person elects to defer conversion until termination of service on Edgewell's Board of Directors. F1 · derivative.expiration_date: Restricted stock equivalents convert into shares of Edgewell Common Stock on the day preceding the next annual meeting of shareholders unless Reporting Person elects to defer conversion until termination of service on Edgewell's Board of Directors. Read SEC document |
| November 29, 2019 Filed Dec 3, 2019 00:41 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 6,496 | $0.00 | $0.00 |
DisclosureSEC source: 0000950138-19-000573 · edgar.xml · nonDerivative · entry 1 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,075 F1 · price: Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors. Read SEC document |
| August 22, 2019 Filed Aug 26, 2019 11:52 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | PurchaseCommon Stock | 15,000 | $26.96 | $404,400.00 |
DisclosureSEC source: 0000950138-19-000472 · edgar.xml · nonDerivative · entry 2 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Suzanne A. Hoover Revocable Trust Disclosed balance after: 15,920 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $26.882 to $27.293, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| August 09, 2019 Filed Aug 12, 2019 18:08 UTC | EDGEWELL PERSONAL CARE Co EPC · Entity 4787 | PurchaseCommon Stock | 2,000 | $29.92 | $59,840.00 |
DisclosureSEC source: 0001209191-19-045467 · doc4.xml · nonDerivative · entry 5 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Suzanne A. Hoover Revocable Trust Disclosed balance after: 10,000 Read SEC document |
| August 09, 2019 Filed Aug 12, 2019 18:08 UTC | EDGEWELL PERSONAL CARE Co EPC · Entity 4787 | PurchaseCommon Stock | 2,000 | $30.15 | $60,300.00 |
DisclosureSEC source: 0001209191-19-045467 · doc4.xml · nonDerivative · entry 4 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Suzanne A. Hoover Revocable Trust Disclosed balance after: 8,000 Read SEC document |
| August 09, 2019 Filed Aug 12, 2019 18:08 UTC | EDGEWELL PERSONAL CARE Co EPC · Entity 4787 | PurchaseCommon Stock | 2,000 | $30.59 | $61,186.80 |
DisclosureSEC source: 0001209191-19-045467 · doc4.xml · nonDerivative · entry 3 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Suzanne A. Hoover Revocable Trust Disclosed balance after: 6,000 Read SEC document |
| August 08, 2019 Filed Aug 12, 2019 18:08 UTC | EDGEWELL PERSONAL CARE Co EPC · Entity 4787 | PurchaseCommon Stock | 1,500 | $31.36 | $47,040.00 |
DisclosureSEC source: 0001209191-19-045467 · doc4.xml · nonDerivative · entry 2 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Suzanne A. Hoover Revocable Trust Disclosed balance after: 4,000 Read SEC document |
| August 08, 2019 Filed Aug 12, 2019 18:08 UTC | EDGEWELL PERSONAL CARE Co EPC · Entity 4787 | PurchaseCommon Stock | 2,500 | $31.42 | $78,550.00 |
DisclosureSEC source: 0001209191-19-045467 · doc4.xml · nonDerivative · entry 1 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Suzanne A. Hoover Revocable Trust Disclosed balance after: 2,500 Read SEC document |
| May 15, 2019 Filed May 15, 2019 18:17 UTC | EDGEWELL PERSONAL CARE Co EPC · Entity 4787 | PurchaseCommon Stock | 3,000 | $33.00 | $99,000.00 |
DisclosureSEC source: 0001209191-19-029917 · doc4.xml · nonDerivative · entry 6 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,885 Read SEC document |
| May 15, 2019 Filed May 15, 2019 18:17 UTC | EDGEWELL PERSONAL CARE Co EPC · Entity 4787 | PurchaseCommon Stock | 2,500 | $33.03 | $82,575.00 |
DisclosureSEC source: 0001209191-19-029917 · doc4.xml · nonDerivative · entry 5 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,885 Read SEC document |
| May 15, 2019 Filed May 15, 2019 18:17 UTC | EDGEWELL PERSONAL CARE Co EPC · Entity 4787 | PurchaseCommon Stock | 2,500 | $32.85 | $82,125.00 |
DisclosureSEC source: 0001209191-19-029917 · doc4.xml · nonDerivative · entry 4 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,385 Read SEC document |
| May 14, 2019 Filed May 15, 2019 18:17 UTC | EDGEWELL PERSONAL CARE Co EPC · Entity 4787 | PurchaseCommon Stock | 2,000 | $33.82 | $67,640.00 |
DisclosureSEC source: 0001209191-19-029917 · doc4.xml · nonDerivative · entry 3 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,885 Read SEC document |
| May 13, 2019 Filed May 15, 2019 18:17 UTC | EDGEWELL PERSONAL CARE Co EPC · Entity 4787 | PurchaseCommon Stock | 2,500 | $32.75 | $81,875.00 |
DisclosureSEC source: 0001209191-19-029917 · doc4.xml · nonDerivative · entry 2 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,885 Read SEC document |
| May 13, 2019 Filed May 15, 2019 18:17 UTC | EDGEWELL PERSONAL CARE Co EPC · Entity 4787 | PurchaseCommon Stock | 2,500 | $32.54 | $81,350.00 |
DisclosureSEC source: 0001209191-19-029917 · doc4.xml · nonDerivative · entry 1 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,385 Read SEC document |
| April 11, 2019 Filed Apr 12, 2019 21:35 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 2,783 | $0.00 | $0.00 |
DisclosureSEC source: 0000950138-19-000246 · edgar.xml · nonDerivative · entry 1 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,579 F1 · price: Grant of deferred stock units to each of the non-employee members of the Issuer's Board of Directors, vesting three years from the date of grant. Read SEC document |
| March 13, 2019 Filed Mar 14, 2019 22:16 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | PurchaseCommon Stock | 20,000 | $31.43 | $628,586.00 |
DisclosureSEC source: 0000950138-19-000154 · edgar.xml · nonDerivative · entry 1 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Revocable Trust Disclosed balance after: 20,000 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $31.38 to $31.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| March 11, 2019 Filed Mar 13, 2019 21:51 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | PurchaseCommon Stock | 920 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950138-19-000129 · edgar.xml · nonDerivative · entry 1 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Suzanne A. Hoover Revocable Trust Disclosed balance after: 920 F1 · price: On March 11, 2019, Eli Lilly and Company ("Lilly") announced the completion of its offer to exchange shares of Lilly common stock for all of the common stock of the Issuer owned by Lilly (the "Exchange Offer"). The Reporting Person tendered 1,500 shares of Lilly common stock in the Exchange Offer, which shares were subject to a proration factor of 13.5970839%. As a result, the Reporting Person received 920 shares of Issuer common stock in exchange for 204 shares of Lilly common stock accepted in the Exchange Offer, based on an exchange ratio of 4.5121 shares of Issuer common stock for each share of Lilly common stock accepted. Read SEC document |
| February 01, 2019 Filed Feb 5, 2019 20:44 UTC | EDGEWELL PERSONAL CARE Co EPC · Entity 4787 | GrantRestricted Stock Equivalent 02/01/2019 · Derivative | 3,156 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-007276 · doc4.xml · derivative · entry 1 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,156 Underlying: Common Stock · 3,156 shares Expires not disclosed F1 · derivative.exercise_date: Restricted stock equivalents convert into shares of Edgewell Common Stock on the day preceding the next annual meeting of shareholders unless Reporting Person elects to defer conversion until termination of service on Edgewell's Board of Directors. F1 · derivative.expiration_date: Restricted stock equivalents convert into shares of Edgewell Common Stock on the day preceding the next annual meeting of shareholders unless Reporting Person elects to defer conversion until termination of service on Edgewell's Board of Directors. Read SEC document |
| November 30, 2018 Filed Dec 4, 2018 21:16 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 1,796 | $0.00 | $0.00 |
DisclosureSEC source: 0000950138-18-000634 · edgar.xml · nonDerivative · entry 1 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,796 F1 · price: Grant of deferred stock as an annual equity award to independent members of the Board of Directors. Read SEC document |
| September 24, 2018 Filed Sep 26, 2018 20:19 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | PurchaseCommon Stock | 10,000 | $24.00 | $240,000.00 |
DisclosureSEC source: 0001140361-18-039152 · form4.xml · nonDerivative · entry 1 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Read SEC document |
| July 09, 2018 Filed Jul 11, 2018 18:21 UTC | EDGEWELL PERSONAL CARE Co EPC · Entity 4787 | Exercise / conversionRestricted Stock Equivalent 07/08/2015 · Derivative | 2,002 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-042279 · doc4.xml · derivative · entry 2 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,002 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Restricted stock equivalents vested and converted into shares of EPC common stock on 7/9/2018. F1 · derivative.expiration_date: Restricted stock equivalents vested and converted into shares of EPC common stock on 7/9/2018. Read SEC document |
| July 09, 2018 Filed Jul 11, 2018 18:21 UTC | EDGEWELL PERSONAL CARE Co EPC · Entity 4787 | Exercise / conversionCommon Stock | 2,002 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-042279 · doc4.xml · nonDerivative · entry 1 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,885 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 15, 2018 Filed Mar 16, 2018 20:34 UTC | BALL Corp BLL · Entity 3320 | Exercise / conversionStock Appreciation Rights (sars) · Derivative | 200,000 | $0.00 Strike: $12.53 | $0.00 |
DisclosureSEC source: 0001127602-18-011840 · form4.xml · derivative · entry 4 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 200,000 shares Expires 2018-04-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: Exercise of Stock Appreciation Rights (SARs). Read SEC document |
| March 15, 2018 Filed Mar 16, 2018 20:34 UTC | BALL Corp BLL · Entity 3320 | Tax withholdingCommon Stock | 122,221 | $40.97 | $5,007,394.37 |
DisclosureSEC source: 0001127602-18-011840 · form4.xml · nonDerivative · entry 2 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · RDH Trust Disclosed balance after: 971,090 F2 · kind: Shares withheld for the cost of the Stock Appreciation Rights (SARs) and for payment of the tax obligation on the exercise of the Table II SARs. Read SEC document |
| March 15, 2018 Filed Mar 16, 2018 20:34 UTC | BALL Corp BLL · Entity 3320 | Exercise / conversionCommon Stock | 200,000 | $12.53 | $2,505,580.00 |
DisclosureSEC source: 0001127602-18-011840 · form4.xml · nonDerivative · entry 1 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · RDH Trust Disclosed balance after: 1,093,311 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Common stock acquired upon the exercise of Stock Appreciation Rights (SARs). Read SEC document |
| March 15, 2018 Filed Mar 19, 2018 17:45 UTC | BALL Corp BLL · Entity 3320 | OtherDeferred Compensation Company Stock Plan · Derivative | 732.2431 | $40.97 | $30,000.00 |
DisclosureSEC source: 0001127602-18-011974 · form4.xml · derivative · entry 1 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,126.7578 Underlying: Common Stock · 732.2431 shares Expires not disclosed F1 · derivative.exercise_price: Each unit may be settled for a single share of stock or the equivalent amount of cash pursuant to the Ball Corporation Deferred Compensation Company Stock Plan. F2 · kind: Contribution of quarterly directors fees and possible company match in Ball Corporation Deferred Compensation Company Stock Plan. F3 · derivative.exercise_date: Stock units in Ball Corporation's Deferred Compensation Company Stock Plan are distributed upon the separation of service in accordance with the Plan. F3 · derivative.expiration_date: Stock units in Ball Corporation's Deferred Compensation Company Stock Plan are distributed upon the separation of service in accordance with the Plan. Read SEC document |
| March 14, 2018 Filed Mar 15, 2018 15:44 UTC | BALL Corp BLL · Entity 3320 | Exercise / conversionStock Appreciation Rights (sars) · Derivative | 189,800 | $0.00 Strike: $12.53 | $0.00 |
DisclosureSEC source: 0001127602-18-011647 · form4.xml · derivative · entry 4 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 189,800 shares Expires 2018-04-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: Exercise of Stock Appreciation Rights (SARs). Read SEC document |
| March 14, 2018 Filed Mar 15, 2018 15:44 UTC | BALL Corp BLL · Entity 3320 | Tax withholdingCommon Stock | 116,011 | $40.94 | $4,749,490.34 |
DisclosureSEC source: 0001127602-18-011647 · form4.xml · nonDerivative · entry 2 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · RDH Trust Disclosed balance after: 893,032 F2 · kind: Shares withheld for the cost of the Stock Appreciation Rights (SARs) and for payment of the tax obligation on the exercise of the Table II SARs. Read SEC document |
| March 14, 2018 Filed Mar 15, 2018 15:44 UTC | BALL Corp BLL · Entity 3320 | Exercise / conversionCommon Stock | 189,800 | $12.53 | $2,377,814.40 |
DisclosureSEC source: 0001127602-18-011647 · form4.xml · nonDerivative · entry 1 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · RDH Trust Disclosed balance after: 1,009,043 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Common stock acquired upon the exercise of Stock Appreciation Rights (SARs). Read SEC document |
| March 14, 2018 Filed Mar 16, 2018 20:22 UTC Amendment | BALL Corp BLL · Entity 3320 | Exercise / conversionStock Appreciation Rights (sars) · Derivative | 89,800 | $0.00 Strike: $12.53 | $0.00 |
DisclosureSEC source: 0001127602-18-011829 · form4a.xml · derivative · entry 7 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 89,800 shares Expires 2018-04-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · kind: Exercise of Stock Appreciation Rights (SARs). Read SEC document |
| March 14, 2018 Filed Mar 16, 2018 20:22 UTC Amendment | BALL Corp BLL · Entity 3320 | Tax withholdingCommon Stock | 54,889 | $40.94 | $2,247,155.66 |
DisclosureSEC source: 0001127602-18-011829 · form4a.xml · nonDerivative · entry 4 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · RDH Trust Disclosed balance after: 893,311 F3 · kind: Shares withheld for the cost of the Stock Appreciation Rights (SARs) and for payment of the tax obligation on the exercise of the Table II SARs. Read SEC document |
| March 14, 2018 Filed Mar 16, 2018 20:22 UTC Amendment | BALL Corp BLL · Entity 3320 | Exercise / conversionCommon Stock | 89,800 | $12.53 | $1,125,014.40 |
DisclosureSEC source: 0001127602-18-011829 · form4a.xml · nonDerivative · entry 3 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · RDH Trust Disclosed balance after: 948,200 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Common stock acquired upon the exercise of Stock Appreciation Rights (SARs). F2 · kind: Due to an administrative error, two transactions were combined into one transaction for 189,800 shares, and should have been two transactions for 100,000 shares and 89,800 shares. Correcting entries. Read SEC document |
| March 13, 2018 Filed Mar 16, 2018 20:22 UTC Amendment | BALL Corp BLL · Entity 3320 | Exercise / conversionStock Appreciation Rights (sars) · Derivative | 100,000 | $0.00 Strike: $12.53 | $0.00 |
DisclosureSEC source: 0001127602-18-011829 · form4a.xml · derivative · entry 6 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 289,800 Underlying: Common Stock · 100,000 shares Expires 2018-04-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · kind: Exercise of Stock Appreciation Rights (SARs). Read SEC document |
| March 13, 2018 Filed Mar 16, 2018 20:22 UTC Amendment | BALL Corp BLL · Entity 3320 | Tax withholdingCommon Stock | 60,843 | $41.62 | $2,532,285.66 |
DisclosureSEC source: 0001127602-18-011829 · form4a.xml · nonDerivative · entry 2 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · RDH Trust Disclosed balance after: 858,400 F3 · kind: Shares withheld for the cost of the Stock Appreciation Rights (SARs) and for payment of the tax obligation on the exercise of the Table II SARs. Read SEC document |
| March 13, 2018 Filed Mar 16, 2018 20:22 UTC Amendment | BALL Corp BLL · Entity 3320 | Exercise / conversionCommon Stock | 100,000 | $12.53 | $1,252,800.00 |
DisclosureSEC source: 0001127602-18-011829 · form4a.xml · nonDerivative · entry 1 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · RDH Trust Disclosed balance after: 919,243 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Common stock acquired upon the exercise of Stock Appreciation Rights (SARs). F2 · kind: Due to an administrative error, two transactions were combined into one transaction for 189,800 shares, and should have been two transactions for 100,000 shares and 89,800 shares. Correcting entries. Read SEC document |
| March 08, 2018 Filed Mar 9, 2018 17:14 UTC | BALL Corp BLL · Entity 3320 | Exercise / conversionStock Option (iso) (Right to Buy) · Derivative | 2,200 | $0.00 Strike: $12.53 | $0.00 |
DisclosureSEC source: 0001127602-18-010876 · form4.xml · derivative · entry 8 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,200 shares Expires 2018-04-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · kind: Exercise of Incentive Stock Options (ISOs). F7 · derivative.exercise_date: Shares exercisable beginning one year after grant in 25% increments and thereafter annually upon the anniversary of the date of the grant of the Incentive Stock Option. Read SEC document |
| March 08, 2018 Filed Mar 9, 2018 17:14 UTC | BALL Corp BLL · Entity 3320 | SaleCommon Stock | 2,200 | $40.71 | $89,562.00 |
DisclosureSEC source: 0001127602-18-010876 · form4.xml · nonDerivative · entry 4 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 192,393.7328 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.